Literature DB >> 11979250

Long-term outcome in patients with benign biliary strictures treated endoscopically with multiple stents.

Peter Draganov1, Brenda Hoffman, William Marsh, Peter Cotton, John Cunningham.   

Abstract

BACKGROUND: The long-term efficacy of sequential insertion of multiple plastic stents for benign biliary strictures is poorly defined. The aims of this study were to evaluate the long-term outcome (bile duct patency, complications) of this therapy and to identify predictors of a good outcome.
METHODS: Retrospective review of 29 cases of benign biliary strictures treated with sequential plastic stent insertion in progressively increasing numbers and/or of increasing diameter.
RESULTS: Stricture etiology was as follows: postoperative 19 (66%), chronic pancreatitis 9 (31%), and idiopathic 1 (3%). Therapy succeeded in 18 patients (62%) (mean follow-up 48.0 [11.56] months after stent removal). Therapy failed in 11 patients (38%) (mean interval to failure 11.59 [9.79] months after stent removal). The 2 groups of patients in which therapy failed had either a hilar stricture (n = 4, 25% success) or distal common bile duct stricture caused by chronic pancreatitis (n = 9, 44% success). In the remaining cases, therapy succeeded in 13 of 16 (81% success). The observed differences in success rate among subgroups were not statistically significant. There were no ERCP-related deaths. One episode of mild pancreatitis and 2 episodes of cholangitis developed during 126 ERCPs over a period of stent insertion of 36 patient years.
CONCLUSIONS: In selected patients with benign biliary strictures, sequential endoscopic insertion of multiple biliary stents may lead to long-term success that could be equal to or superior to surgery with minimal morbidity. Hilar strictures and those caused by chronic pancreatitis appear to respond poorly to this therapy.

Entities:  

Mesh:

Year:  2002        PMID: 11979250     DOI: 10.1067/mge.2002.122955

Source DB:  PubMed          Journal:  Gastrointest Endosc        ISSN: 0016-5107            Impact factor:   9.427


  55 in total

1.  A New Fully Covered Self-Expandable Metal Stent for the Treatment of Postsurgical Benign Biliary Strictures.

Authors:  Jun Wu; Dong-Xun Zhou; Tian-Tian Wang; Dao-Jian Gao; Bing Hu
Journal:  Dig Dis Sci       Date:  2017-08-03       Impact factor: 3.199

2.  Management of benign biliary strictures.

Authors:  Michael F Byrne
Journal:  Gastroenterol Hepatol (N Y)       Date:  2008-10

Review 3.  Endoscopic management of benign biliary strictures.

Authors:  Kavel H Visrodia; James H Tabibian; Todd H Baron
Journal:  World J Gastrointest Endosc       Date:  2015-08-25

4.  What is the role of endotherapy in chronic pancreatitis?

Authors:  Haritha Avula; Stuart Sherman
Journal:  Therap Adv Gastroenterol       Date:  2010-11       Impact factor: 4.409

Review 5.  Endoscopic therapy of benign biliary strictures.

Authors:  Joel R Judah; Peter V Draganov
Journal:  World J Gastroenterol       Date:  2007-07-14       Impact factor: 5.742

6.  Biliary tract obstruction in chronic pancreatitis.

Authors:  Abdul A Abdallah; Jake E J Krige; Philippus C Bornman
Journal:  HPB (Oxford)       Date:  2007       Impact factor: 3.647

Review 7.  Endoscopic management of benign biliary strictures.

Authors:  Jesús García-Cano
Journal:  Curr Gastroenterol Rep       Date:  2013-08

8.  Endoscopic treatment of benign biliary strictures using covered self-expandable metal stents (CSEMS).

Authors:  Shayan Irani; Todd H Baron; Ali Akbar; Otto S Lin; Michael Gluck; Ian Gan; Andrew S Ross; Bret T Petersen; Mark Topazian; Richard A Kozarek
Journal:  Dig Dis Sci       Date:  2013-09-24       Impact factor: 3.199

Review 9.  Endoscopic retrograde cholangiopancreatography in the management of benign biliary strictures.

Authors:  Myriam Farah; Mark McLoughlin; Michael F Byrne
Journal:  Curr Gastroenterol Rep       Date:  2008-04

10.  Diminished Survival in Patients with Bile Leak and Ductal Injury: Management Strategy and Outcomes.

Authors:  Zhi Ven Fong; Henry A Pitt; Steven M Strasberg; Andrew P Loehrer; Jason K Sicklick; Mark A Talamini; Keith D Lillemoe; David C Chang
Journal:  J Am Coll Surg       Date:  2018-01-04       Impact factor: 6.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.